After finishing at $0.37 in the prior trading day, Cns Pharmaceuticals Inc (NASDAQ: CNSP) closed at $0.39, up 4.84%. In other words, the price has increased by $+0.0179 from its previous closing price. On the day, 547384 shares were traded.
Ratios:
Our goal is to gain a better understanding of CNSP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.51 and its Current Ratio is at 0.51.
On August 24, 2020, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 01 when Climaco John M bought 166,666 shares for $0.30 per share. The transaction valued at 50,000 led to the insider holds 215,676 shares of the business.
Downs Christopher bought 66,666 shares of CNSP for $20,000 on Feb 01. The Chief Financial Officer now owns 103,438 shares after completing the transaction at $0.30 per share. On Feb 01, another insider, Evans Carl Anthony, who serves as the Director of the company, bought 33,333 shares for $0.30 each. As a result, the insider paid 10,000 and bolstered with 33,458 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNSP now has a Market Capitalization of 3.27M and an Enterprise Value of 2.40M.
Stock Price History:
Over the past 52 weeks, CNSP has reached a high of $4.40, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is 0.6196, while the 200-Day Moving Average is calculated to be 1.5536.
Shares Statistics:
The stock has traded on average 388.09K shares per day over the past 3-months and 347.14k shares per day over the last 10 days, according to various share statistics. A total of 8.43M shares are outstanding, with a floating share count of 7.89M. Insiders hold about 6.38% of the company’s shares, while institutions hold 3.98% stake in the company. Shares short for CNSP as of Feb 15, 2024 were 102.55k with a Short Ratio of 0.26, compared to 192.42k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.22% and a Short% of Float of 1.23%.
Earnings Estimates
Its stock is currently analyzed by 0 different market analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$3. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
